Ghana’s Leading Industrial Zone for the Pharmaceutical Industry.

Brief Insight Into Ghana’s Pharmaceutical Industry.

Geographically speaking, Ghana is in West Africa between the Atlantic Ocean and the Gulf of Guinea. encompassing 2.4 million square kilometers and having a population of about 30 million. Ghana’s industries just slightly power the country’s economy.

Ghana’s pharmaceutical industry features both private and public entities. Worldwide, an estimated 2000–2500 registered pharmaceutical businesses serve populous villages and towns. On the other hand, private businesses have a lot of space for expansion because they can focus on any phase of the manufacturing process and then sell their products to pharmacies or hospitals.

Pharmaceutical firms are greatly favoured by the existing regulations and rules. They have the most straightforward rules for pharmaceutical businesses to follow when registering, licensing, and advertising their goods. Every business adheres to GDP (Good Distribution Practices) and GMP (Good Manufacturing Practices) rules set by the government. Once they are satisfied, a business can quickly obtain a license to operate its plants in Ghana. The Food and Drugs Board (FDB) and the Medicines Regulatory Authority are the two authorities that disregard clinical studies and marketing and advertising (MRA).

Ghana’s pharmaceutical industry has grown significantly over the last 20 years. The importance of finding better hospitals, facilities, and medications has increased for important stakeholders in this sector. Significantly, as a result of COVID-19 vaccines, Ghana—one of just two sub-Saharan African nations that produce active pharmaceutical ingredients—is quickly developing into the region’s center of pharmaceutical production. Just last month, Rwandan president, Paul Kagame, broke ground for the production site of the BioNTech COVID-19 vaccine facility. Again, President Akufo-Addo cut the sod for production to begin at the Atlantic LifeScience Pharmaceutical Manufacturing Plant which was recently opened at Ningo Prampram.

Why DIZ is the Best Choice For Your Pharmaceutical Industry.

The government’s backing of the robust healthcare infrastructure has aided the industry’s rise to a new dawn. For pharmaceutical companies to start large-scale operations, it became necessary to create a pharmaceutical industrial park to carry out operations that will facilitate pharmaceutical market growth.

The Ghana National Chamber of Pharmacy (GNCP) with funding from foreign and development organisations has created a support package of $626,000 which will be used to provide grants to pharmaceutical manufacturers, distributors, and consulting firms within the pharmaceutical sector. Ultimately, the purpose of this is to provide support to companies to address vulnerabilities in the pharmaceutical supply chain, among others.

The Dawa Industrial Zone (DIZ) has signed an MOU with the GNCP and given them bespoke infrastructure and funding support to set up all their local pharmaceutical manufacturing plants in DIZ. Thus, making our 140-acre fully serviced industrial zone the premiere spot for all pharmaceutical developments. The Dawa Industrial Zone is a purposefully designed industrial enclave intended to host a wide range of light and heavy industries across various sectors including the pharmaceutical industry.

Seize the opportunity now to build your industry on Dawa land and benefit from our 132MVA substation capable of accommodating energy-intensive industries including the pharmaceutical industry; our first-class reinforced asphalted and paved block roads with streetlights; our 4000m3/day water treatment plant; ultra-fast fibre broadband internet and data facilities, and other unmatchable advantages.

Call us NOW!

Contact Investor Relations:
Tel: 0552030000 / 0552040000

Newsletter image
Get the latest news stories and exclusive DIZ insights directly into your email.